Lip and Oral Cavity Cancer


Opdivo Approved for Advanced Head and Neck Cancer (November 28, 2016)

The United States Food and Drug Administration (FDA) has approved the immunotherapeutic agent, Opdivo® (nivolumab) for the treatment of advanced head and neck cancer. Specifically,  the indication is... Continue Reading

Head and Neck Cancer- Your Questions Answered (October 17, 2016)

CancerConnect and The Ohio State University Comprehensive Cancer Center- James Cancer Hospital and Solove Research Institute Present: Ask the Expert with Dr. Kang CancerConnect in collaboration with The... Continue Reading

Ask the Head and Neck Cancer Expert- Q&A Now Available! (October 14, 2016)

CancerConnect and The Ohio State University Comprehensive Cancer Center- James Cancer Hospital and Solove Research Institute Will Present: Ask the Expert with Dr. Kang CancerConnect in collaboration with... Continue Reading

Announcing the CancerConnect Head and Neck Cancer Support Community (September 14, 2016)

Your story matters. Head and neck cancer is a challenging diagnosis, connecting with others who have had to deal with the side effects of treatment and the challenges of treatment decision making is an... Continue Reading

Lip and Oral Cavity Cancer (June 28, 2016)

Lip and oral cavity cancer is a disease in which cancer cells form in the lips or mouth.  The oral cavity includes the lips, hard palate (the bony front portion of the roof of the mouth), soft palate... Continue Reading

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS